GlobeNewswire Inc | Sep 8, 2020 07:05AM EDT

September 08, 2020

NESS ZIONA, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Sol-Gel Technologies (NASDAQ: SLGL), (Sol-Gel), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases,today announced that the company will present at the following upcoming virtual investor conferences.

Dr. Alon Seri-Levy, Sol-Gels Chief Executive Officer, will provide an overview of the Company and give a business update. A live webcast of the presentation will be available under the Events and Presentations in the investors section of the Companys website at www.sol-gel.com. An archived webcast recording of the event will be available on the website for approximately 30 days.

H.C. Wainwright Healthcare Conference Speaker: Gilad Mamlok, Chief Financial OfficerDate: September 15, 2020Time: 10:00 AM ET Cantor Fitzgerald Virtual Global Healthcare Conference ? Fireside Chat Speakers: Dr. Alon Seri-Levy, Chief Executive Officer Gilad Mamlok, Chief Financial Officer John Vieira, U.S. Head of CommercializationDate: September 17, 2020Time: 8:40 AM ET

About Sol-Gel TechnologiesSol-Gelis a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.Sol-Gelleverages its proprietary microencapsulation technology platform for Twyneo, for the treatment of acne vulgaris, and Epsolay, for the treatment of papulopustular rosacea. The Companys pipeline also includes SGT-210, an early-stage topical epidermal growth factor receptor inhibitor, erlotinib, for the treatment of punctatepalmoplantar keratoderma, and preclinical assets tapinarof and roflumilast. For additional information, please visitwww.sol-gel.com.

For further information, please contact:Sol-Gel Contact:Gilad MamlokChief Financial Officer+972-8-9313433

Investor Contact:Lee SternSolebury Trout +1-917-312-5998lstern@soleburytrout.com

Source: Sol-Gel Technologies Ltd.